Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 14 Lymphoma, Non-Hodgkin 10 Breast Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, B-Cell 5 Lymphoma 5 Solid Tumors 4 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Arthritis, Rheumatoid 4 Ovarian Neoplasms 3 Lymphoma, Follicular 3 Leukemia 3 Hematologic Neoplasms 3 Cytokine Release Syndrome 3 Colorectal Neoplasms 3 Burkitt Lymphoma 3 Urinary Bladder Neoplasms 2 Respiratory Distress Syndrome 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Fallopian Tube Neoplasms 2 Craniopharyngioma 2 Carcinoma, Hepatocellular 2

Interventions

rozanolixizumab 10 zilucoplan 8 efgartigimod alfa 8 Rituximab 7 Cyclophosphamide 7 telitacicept 6 fludarabine 6 eculizumab 5 Prednisone 5 ravulizumab 4 Pyridostigmine Bromide 4 Immunoglobulins, Intravenous 4 Hizentra 4 Tacrolimus 3 Mycophenolic Acid 3 HBM9161 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Prednisolone 2 Exercise 2 tofacitinib 1 tocilizumab 1 talquetamab 1 satralizumab 1 sargramostim 1 rhoA GTP-Binding Protein 1 remibrutinib 1 prednylidene 1 iscalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myasthenia Gravis × tocilizumab × Clear all

NCT05716035 2024-01-22

tMG-E

Tang-Du Hospital

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡